Answers are grounded in this paper and cite their sources.
Case series reports findings of CMV retinitis associated with immunocompromised states, indicating significant intraocular inflammation.
This study aims to demonstrate the clinical presentations, diagnosis, and treatment modalities and outcomes for cytomegalovirus (CMV) retinitis in non-human immunodeficiency virus (HIV) immunocompromised states. HIV-seronegative patients treated for CMV retinitis were studied prospectively at a single ophthalmic tertiary care center. Patients completing a minimum of 12 months of follow-up were enrolled. CMV retinitis was diagnosed and managed in nine eyes of five patients. The underlying cause of immunosuppression was as follows: hematologic malignancies (3/5), immunosuppressive therapy for autoimmune disease (1/5), and unknown (1/5). Intraocular inflammation was noticed as frosted branch angiitis (66.7%, 6/9 eyes), significant vitritis (22.2%, 2/9 eyes), and anterior chamber inflammation with AC cells ≥2+ (77.8%, 7/9 eyes). The duration of systemic antiviral therapy necessary for remission was 23.78 ± 3.58 weeks. CMV retinitis in non-HIV acquired immunosuppression incites significant intraocular inflammation in the form of frosted branch angiitis, vitritis, and anterior chamber reaction.
No takes yet. Share an insight, caveat, or question.
Deora et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: